Table 1.
Participants (%), median (IQR), or mean (SD) |
|
---|---|
Hepatitis Cþ | 16 (34) |
Age (years) | 49 (25–66) |
Sex Male | 37 (79) |
Female | 10 (21) |
Ethnic/racial category | |
African American | 15 (32) |
Caucasian | 9 (19) |
Hispanic | 16 (34) |
Other/not reported | 7 (15) |
Years of education | 12.3 (2.0) |
Preferred route of opioid administration | |
Heroin | |
Intranasal | 14 (30) |
Intravenous | 8 (17) |
Prescription opioids | |
Oral | 25 (53) |
Daily equivalent morphine dose (mg)a | 183.9 (162.9) |
Years of opioid use | 13.4 (12.7) |
BDI score | 12.1 (9.5) |
BPI ratings | |
BPI pain severity rating | 6.1 (2.0) |
BPI pain interference rating | 5.0 (2.5) |
SF-36 scales | |
Physical functioning | 55.5 (33.5) |
Role limitations due to physical functioning | 51.6 (46.4) |
Role limitations due to emotional problems | 66.3 (41.7) |
Vitality | 52.8 (21.4) |
Emotional well-being | 68.5 (19.2) |
Social functioning | 67.5 (29.9) |
Pain | 41.3 (24.8) |
General health | 65.4 (23.2) |
Based on reported use over the past month.
Based on most preferred method of administration.